Marker Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:MRKR) | MetaTrader

전체 차트 열기 Full chart

뉴스

MARKER THERAPEUTICS (MRKR) Upgraded to Buy: What Does It Mean for the Stock?

ProKidney Corp. (PROK) Reports Q1 Loss, Tops Revenue Estimates

BioStem Technologies, Inc. (BSEM) Reports Q1 Loss, Tops Revenue Estimates

MARKER THERAPEUTICS, INC. (MRKR) Reports Q4 Loss, Tops Revenue Estimates

Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates

마커 테라퓨틱스, 2026년 주총 날짜 및 제안 마감일 발표

Marker Therapeutics sets date for 2026 annual shareholder meeting and proposal deadline

MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics

MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy?

5 Small Drug Stocks to Buy as Industry Recovery Picks Up

마커 테라퓨틱스, H.C. Wainwright ’매수’ 등급 유지